# Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric

> **NCT03962634** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 3 (actual)

## Conditions studied

- Caries,Dental
- Apical Periodontitis

## Interventions

- **DRUG:** Kovanaze Nasal Spray
- **DRUG:** Articaine Injection

## Key facts

- **NCT ID:** NCT03962634
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-28
- **Primary completion:** 2019-09-17
- **Final completion:** 2019-09-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Drug is no longer being manufactured
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03962634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03962634, "Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03962634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*